Naturally Splendid Appoints VP of E-Commerce

Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to announce that Mr. Kris Tarr has accepted the position of VP of E-Commerce with the Company

Mr. Tarr initially joined Naturally Splendid as an Advisor in November 2020 and increased his role on February 3, 2021, as announced in an earlier news release. With this announcement, Kris increases his role further developing and implementing the Company's e-commerce and social media strategies as VP of E-Commerce.

Kris has worked for globally recognized organizations such as Coca-Cola, Disney, and Nickelodeon. In his career, he has pioneered e-commerce and social media strategies for a wide variety of clients ranging from global corporations to regional enterprises. This range of experience fits well with Naturally Splendid strategies as the process of building out a sophisticated online and e-commerce presence continues.

A survey by Dalhousie University reported that in 2019, barely 4% of Canadians were buying food online. As of April 2020, the report cited that 22% of Canadians are thinking of purchasing food online regularly even after the pandemic crisis is over.

Mr. Kris Tarr states, "I have been at the forefront of e-commerce and digital marketing for over two decades. In my time I have witnessed the shift in consumer trends to online purchases but never as dramatic as the last year during the pandemic. The need to shop safely began the acceleration of this trend. However, I firmly believe now that shoppers have become more accustomed to online shopping, this trend will continue to gain in popularity, and I look forward to bringing my decades of experience to Naturally Splendid to optimize this opportunity".

Naturally Splendid CEO Mr. Craig Goodwin states, "An online strategy has never been more important. Issues like safety, availability, and convenience are increasingly important considerations for a growing number of shoppers. In the time we have worked with Kris, he has exceeded expectations as we continue to build out our e-commerce strategies. We are most fortunate to have Kris leading the team during such a pivotal time as consumer trends continue to drive increased e-commerce transactions".

About Naturally Splendid Enterprises Ltd.

Founded in 2010, NSE operates a Safe Quality Food Level 2 certified food manufacturing facility just outside Vancouver, BC in Canada. The Company has established numerous healthy, functional foods under recognized brands such as Natera Sport™, Natera Hemp Foods, CHII, Elevate Me™ and Woods Wild Bar™, and most recently Natera Plant Based Foods, a line of delicious plant-based meat alternatives for the rapidly growing plant-based market segment.

The Company has a myriad of new products and line extensions under development that are approaching launch. NSE, through its joint venture Plasm Pharmaceutical, has been approved for conducting a phase 2 clinical trial approved by Health Canada for treatment of COVID-19.

NSE has also developed proprietary technologies for the extraction of high-demand, healthy omega 3 and 6 oils from hemp.

NSE contract manufacturers for healthy, functional food products and ingredients focusing on plant-based ingredients. The Company provides contract manufacturing services for many healthy food companies, private labeling a wide variety of nutritional food products destined for global healthy food markets.

For more information e-mail or call Investor Relations at 604-465-0548 ext.105

On Behalf of the Board of Directors
Mr. J. Craig Goodwin
CEO, Director

Contact Information

Naturally Splendid Enterprises Ltd.
(NSP - TSX Venture; NSPDF - OTCQB; 50N - Frankfurt)
#108-19100 Airport Way
Pitt Meadows, BC, V3Y 0E2
Office: (604) 465-0548
Fax: (604) 465-1128

SOURCE: Naturally Splendid Enterprises Ltd.

View source version on

News Provided by ACCESSWIRE via QuoteMedia

The Conversation (0)
Naturally Splendid Enterprises

Naturally Splendid Enterprises

Keep reading...Show less
Boosh Announces the Closing of its Private Placement Offering and Opens Listing Issuer Exemption Offering

Boosh Announces the Closing of its Private Placement Offering and Opens Listing Issuer Exemption Offering

Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or the "Company") a premier plant-based brand in the "better for you" food sector, is pleased to announce that it has closed the second and final tranche of its previously announced non-brokered private placement financing. In total, the Company has raised $362,000.00 CAD via the sale of 7,240,000 Units. Each Unit is comprised of one Common Share of the Company and one Purchase Warrant, with each Warrant exercisable into one Common Share of the Company at a price of $0.07 CAD at any time on or before the date which is 12 months from the closing of the offering. In connection with the offering, the Company paid $1,750.00 CAD in finders fees. Proceeds from the Offering will be used for general working capital purposes and to further advance the Company's business.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

AbbVie Showcases Strength of Dermatology Portfolio with New Data Presented at the 2023 AAD Annual Meeting

- More than 20 abstracts, including one late-breaking presentation, underscore AbbVie's dedication to advancing care for dermatologic conditions

ABBVie (NYSE: ABBV) today announced it will present more than 20 abstracts, including one late-breaking presentation during the 2023 American Academy of Dermatology (AAD) Annual Meeting, March 17-21 in New Orleans, Louisiana .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Aptose Reports Immaterial Financial Exposure to Silicon Valley Bank

Aptose Biosciences Inc. ("Aptose" or the "Company") (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, is aware of reports related to Silicon Valley Bank ("SVB") and questions raised by interested parties.

Aptose has not entered into a line of credit with SVB, and therefore has no exposure related to any credit facility.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less


Amgen (NASDAQ:AMGN) will present at the 2023 Oppenheimer Healthcare Conference at 2:00 p.m. ET on Monday, March 13, 2023 . Susan Sweeney senior vice president, Global Marketing, Access and Capabilities at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Aptose to Report Fourth Quarter and Full Year 2022 Financial Results and Hold Conference Call on Thursday, March 23, 2023

Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, will report financial results for the fourth quarter and full year ended December 31, 2022, on Thursday, March 23, 2023, after the close of the market, and provide a corporate update.

Conference Call & Webcast:

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Bristol Myers Squibb to Report Results for First Quarter 2023 on April 27, 2023

Bristol Myers Squibb (NYSE: BMY) will announce results for the first quarter of 2023 on Thursday, April 27, 2023. Company executives will review financial results and address inquiries from investors and analysts during a conference call beginning at 8:00 a.m. ET on the same date.

Investors and the general public are invited to listen to a live webcast of the call at . Investors and the public can also access the live conference call by dialing in the U.S. toll free 888-300-3045 or international +1 646-568-1027, conference code: 3734085. Materials related to the call will be available at prior to the start of the conference call.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News